2252 fundamentals
Key facts
About
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. Its product portfolio covers surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures. Its products include Toumai, DFVision, and SkyWalker. The company was founded on May 11, 2015 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−3,400.0%
−2,600.0%
−1,800.0%
−1,000.0%
−200.0%
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−780.00 M
−520.00 M
−260.00 M
0.00
260.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
No dividends
2252 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company